158 related articles for article (PubMed ID: 28089441)
1. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
[TBL] [Abstract][Full Text] [Related]
2. Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.
Kaufmann H; Krömer E; Nösslinger T; Weltermann A; Ackermann J; Reisner R; Bernhart M; Drach J
Eur J Haematol; 2003 Sep; 71(3):179-83. PubMed ID: 12930318
[TBL] [Abstract][Full Text] [Related]
3. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
5. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytogenetics in multiple myeloma.
Seong C; Delasalle K; Hayes K; Weber D; Dimopoulos M; Swantkowski J; Huh Y; Glassman A; Champlin R; Alexanian R
Br J Haematol; 1998 Apr; 101(1):189-94. PubMed ID: 9576200
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13.
Avet-Louseau H; Daviet A; Sauner S; Bataille R;
Br J Haematol; 2000 Dec; 111(4):1116-7. PubMed ID: 11227093
[TBL] [Abstract][Full Text] [Related]
9. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
[TBL] [Abstract][Full Text] [Related]
10. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
Fonseca R; Oken MM; Harrington D; Bailey RJ; Van Wier SA; Henderson KJ; Kay NE; Van Ness B; Greipp PR; Dewald GW
Leukemia; 2001 Jun; 15(6):981-6. PubMed ID: 11417487
[TBL] [Abstract][Full Text] [Related]
11. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
[TBL] [Abstract][Full Text] [Related]
12. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.
Zojer N; Königsberg R; Ackermann J; Fritz E; Dallinger S; Krömer E; Kaufmann H; Riedl L; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
Blood; 2000 Mar; 95(6):1925-30. PubMed ID: 10706856
[TBL] [Abstract][Full Text] [Related]
13. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
15. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
[TBL] [Abstract][Full Text] [Related]
16. Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma.
Fassas AB; Spencer T; Sawyer J; Zangari M; Lee CK; Anaissie E; Muwalla F; Morris C; Barlogie B; Tricot G
Br J Haematol; 2002 Sep; 118(4):1041-7. PubMed ID: 12199783
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
Hogan WJ; Tefferi A; Borell TJ; Jenkins R; Li CY; Witzig TE
Cancer Genet Cytogenet; 1999 Apr; 110(2):77-81. PubMed ID: 10214353
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia.
Lloveras E; Granada I; Zamora L; Espinet B; Florensa L; Besses C; Xandri M; Pérez-Vila ME; Millà F; Woessner S; Solé F
Cancer Genet Cytogenet; 2004 Jan; 148(1):71-6. PubMed ID: 14697644
[TBL] [Abstract][Full Text] [Related]
19. Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.
Chang H; Bouman D; Boerkoel CF; Stewart AK; Squire JA
Leukemia; 1999 Jan; 13(1):105-9. PubMed ID: 10049044
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.
Espinet B; Salido M; Pujol RM; Florensa L; Gallardo F; Domingo A; Servitje O; Estrach T; Garcìa-Muret P; Woessner S; Serrano S; Solé F
Haematologica; 2004 Feb; 89(2):165-73. PubMed ID: 15003891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
